Two Sigma Investments, LP Cor Medix Inc. Transaction History

Two Sigma Investments, LP

  • $50.6 Billion
  • Q2 2025

A detailed history of Two Sigma Investments, LP transactions in Cor Medix Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 316,963 shares of CRMD stock, worth $3.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
316,963
Previous 27,950 1034.04%
Holding current value
$3.59 Million
Previous $172,000 2169.77%
% of portfolio
0.01%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$5.86 - $16.56 $1.69 Million - $4.79 Million
289,013 Added 1034.04%
316,963 $3.9 Million
Q1 2025

May 15, 2025
SELL
$6.16 - $12.57 $21,800 - $44,485
-3,539 Reduced 11.24%
27,950 $172,000
Q4 2024

Feb 14, 2025
BUY
$8.1 - $13.59 $42,030 - $70,518
5,189 Added 19.73%
31,489 $255,000
Q3 2024

Nov 14, 2024
SELL
$3.64 - $8.23 $474,787 - $1.07 Million
-130,436 Reduced 83.22%
26,300 $212,000
Q2 2024

Aug 14, 2024
BUY
$4.08 - $6.39 $382,504 - $599,068
93,751 Added 148.85%
156,736 $678,000
Q1 2024

May 15, 2024
SELL
$2.94 - $4.24 $337,373 - $486,552
-114,753 Reduced 64.56%
62,985 $267,000
Q4 2023

Feb 14, 2024
SELL
$3.0 - $4.01 $152,613 - $203,992
-50,871 Reduced 22.25%
177,738 $668,000
Q3 2023

Nov 14, 2023
BUY
$3.6 - $4.46 $682,232 - $845,210
189,509 Added 484.68%
228,609 $845,000
Q2 2023

Aug 14, 2023
SELL
$3.94 - $5.8 $219,777 - $323,529
-55,781 Reduced 58.79%
39,100 $154,000
Q1 2023

May 15, 2023
SELL
$3.22 - $4.61 $13,800 - $19,758
-4,286 Reduced 4.32%
94,881 $392,000
Q4 2022

Feb 14, 2023
SELL
$2.81 - $4.45 $50,891 - $80,593
-18,111 Reduced 15.44%
99,167 $418,000
Q3 2022

Nov 14, 2022
SELL
$2.82 - $7.52 $241,628 - $644,343
-85,684 Reduced 42.22%
117,278 $332,000
Q2 2022

Aug 15, 2022
BUY
$2.73 - $5.61 $357,728 - $735,111
131,036 Added 182.18%
202,962 $816,000
Q1 2022

May 16, 2022
SELL
$3.83 - $6.24 $126,137 - $205,508
-32,934 Reduced 31.41%
71,926 $394,000
Q4 2021

Feb 14, 2022
SELL
$4.47 - $5.56 $109,059 - $135,652
-24,398 Reduced 18.88%
104,860 $477,000
Q3 2021

Nov 15, 2021
SELL
$4.46 - $7.11 $309,711 - $493,732
-69,442 Reduced 34.95%
129,258 $601,000
Q2 2021

Aug 16, 2021
BUY
$6.05 - $10.09 $1.2 Million - $2 Million
198,700 New
198,700 $1.36 Million
Q1 2021

May 17, 2021
SELL
$6.84 - $17.58 $1.04 Million - $2.68 Million
-152,369 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$5.0 - $9.15 $391,215 - $715,923
78,243 Added 105.55%
152,369 $1.13 Million
Q3 2020

Nov 16, 2020
BUY
$3.96 - $6.15 $78,408 - $121,770
19,800 Added 36.45%
74,126 $447,000
Q2 2020

Aug 14, 2020
BUY
$3.08 - $6.56 $167,324 - $356,378
54,326 New
54,326 $342,000

Others Institutions Holding CRMD

# of Institutions
188
Shares Held
33.2M
Call Options Held
867K
Put Options Held
561K
View Full List

About CorMedix Inc.

CRMD Quotes by TradingView
  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $467M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email